The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2024

Filed:

Jul. 05, 2023
Applicant:

Intarcia Therapeutics, Inc., Boston, MA (US);

Inventors:

William Blackwell, Boston, MA (US);

Ved P. Srivastava, Boston, MA (US);

James M. Way, Boston, MA (US);

Assignee:

i2o Therapeutics, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/575 (2006.01); A61K 38/00 (2006.01); A61P 3/04 (2006.01);
U.S. Cl.
CPC ...
C07K 14/575 (2013.01); A61P 3/04 (2018.01); A61K 38/00 (2013.01);
Abstract

This invention relates to isolated polypeptides that are long acting analogs of human PYY. The disclosed PYY analog polypeptides have beneficial physicochemical properties relative to endogenous PYY and known synthetic PYY analog polypeptides, such as longer (i.e., 'long-acting') elimination half-lives (t), and improved solubility and thermal stability. This invention also relates to methods of using presently disclosed PYY analog polypeptides in a variety of therapeutic indications, as well as methods of producing the same. The disclosed PYY analog polypeptides are particularly useful in methods of treating metabolic diseases or disorders, such as type 2 diabetes, treating obesity, and providing weight loss, and in methods of treating nonalcoholic fatty liver disease (NAFLD) and/or nonalcoholic steatohepatitis (NASH).


Find Patent Forward Citations

Loading…